Zoetis inc. (ZTS)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12
Assets
Cash and cash equivalents

1,951

1,934

1,815

1,755

1,728

1,602

1,286

1,558

1,654

1,564

1,981

705

629

727

651

658

675

1,154

592

544

559

882

598

578

506

610

389

369

468

317

Restricted cash

1

2

4

4

3

5

5

5

6

6

7

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short term investments

-

-

12

25

65

99

105

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, less allowance for doubtful accounts of $21 in 2020 and $21 in 2019

965

1,086

1,030

994

970

1,036

929

973

943

998

1,009

975

954

913

915

888

908

937

1,038

993

905

980

1,057

1,098

1,100

1,138

1,110

1,137

861

900

Receivable from Pfizer Inc.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

222

-

Inventories

1,481

1,410

1,439

1,404

1,361

1,391

1,441

1,420

1,441

1,427

1,490

1,498

1,535

1,502

1,563

1,525

1,461

1,467

1,403

1,417

1,346

1,289

1,388

1,336

1,316

1,293

1,290

1,257

1,120

1,345

Assets held for sale

-

-

-

-

-

-

-

-

-

-

57

53

-

-

0

0

27

71

26

-

-

0

-

-

-

-

-

-

-

-

Current deferred tax assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

127

127

87

109

106

108

95

97

66

92

83

101

Other current assets

375

318

322

306

255

271

315

288

229

228

357

353

265

248

235

257

236

201

264

235

213

205

204

207

205

219

228

227

188

201

Total current assets

4,772

4,748

4,618

4,484

4,379

4,399

4,076

4,239

4,267

4,217

4,894

3,584

3,383

3,390

3,364

3,328

3,307

3,830

3,450

3,316

3,110

3,465

3,353

3,327

3,222

3,357

3,083

3,082

2,942

2,864

Property, plant and equipment, less accumulated depreciation of $1,769 in 2020 and $1,737 in 2019

1,977

1,940

1,813

1,739

1,683

1,658

1,556

1,470

1,453

1,435

1,388

1,355

1,368

1,381

1,382

1,341

1,317

1,307

1,293

1,295

1,301

1,318

1,313

1,309

1,292

1,295

1,252

1,252

1,237

1,241

Operating lease right of use assets

182

189

193

195

158

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

2,583

2,592

2,550

2,505

2,522

2,519

2,537

1,514

1,532

1,510

1,530

1,495

1,497

1,481

1,497

1,475

1,459

1,455

1,163

1,167

1,169

976

982

984

982

982

980

982

985

985

Identifiable intangible assets, less accumulated amortization

1,821

1,890

1,935

1,916

1,989

2,046

2,120

1,225

1,280

1,269

1,318

1,210

1,232

1,228

1,282

1,217

1,210

1,190

679

697

735

727

757

774

787

803

815

834

855

868

Noncurrent deferred tax assets

88

88

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncurrent deferred tax assets

-

-

72

60

65

61

73

80

80

80

94

93

97

96

119

91

112

82

58

65

57

54

55

57

57

63

70

54

63

216

Other noncurrent assets

105

98

91

87

87

94

97

75

78

75

64

65

72

73

71

66

48

49

43

58

58

48

67

71

63

58

59

57

60

88

Total assets

11,528

11,545

11,272

10,986

10,883

10,800

10,459

8,603

8,690

8,600

9,288

7,802

7,649

7,649

7,715

7,518

7,453

7,913

6,686

6,598

6,430

6,588

6,527

6,522

6,403

6,558

6,259

6,261

6,142

6,262

Liabilities and Equity
Long-term Debt, Current Maturities

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term borrowings

500

500

0

0

0

9

-

-

-

-

-

100

-

-

0

4

4

5

8

4

2

7

10

12

16

15

10

12

6

73

Current portion of long-term debt

-

-

-

-

-

-

-

-

-

-

750

750

750

-

0

0

0

400

400

400

400

0

-

-

-

-

-

-

-

-

Accounts payable

265

301

284

290

235

313

238

230

217

261

213

199

231

265

241

224

210

293

306

278

256

290

259

337

363

506

482

587

275

319

Dividends payable

95

95

0

78

79

79

0

61

61

61

0

52

52

52

0

47

49

47

0

0

42

42

0

0

36

36

33

33

33

0

Accrued expenses

476

543

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

451

443

448

487

425

434

419

432

413

406

383

464

457

512

552

676

599

627

426

475

-

-

-

570

-

-

-

-

Payable to Pfizer Inc.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

383

-

Accrued compensation and related items

212

276

217

178

200

266

226

160

182

236

202

163

183

224

204

164

166

234

197

165

173

238

201

172

177

229

184

157

132

194

Income taxes payable

123

36

52

31

65

35

75

53

92

60

128

82

100

71

95

51

118

63

91

59

41

26

86

97

84

40

121

83

49

30

Liabilities associated with assets held for sale

-

-

-

-

-

-

-

-

-

-

6

4

-

-

0

0

4

4

-

-

-

0

-

-

-

-

-

-

-

-

Other current liabilities

50

55

48

55

55

34

39

29

29

44

34

28

31

41

42

37

60

59

57

39

30

8

442

443

451

19

478

449

409

507

Total current liabilities

1,721

1,806

1,052

1,075

1,082

1,223

1,003

967

1,000

1,094

1,746

1,784

1,730

1,117

1,039

1,039

1,163

1,781

1,658

1,572

1,370

1,086

998

1,061

1,127

1,415

1,308

1,321

1,287

1,123

Long-term debt, net of discount and issuance costs

5,963

5,947

6,447

6,446

6,444

6,443

6,441

4,955

4,954

4,953

4,952

3,719

3,718

4,468

4,467

4,465

4,464

4,463

3,226

3,243

3,243

3,624

3,642

3,642

3,642

3,642

3,642

3,640

3,640

0

Noncurrent deferred tax liabilities

421

434

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Allocated long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

509

Noncurrent deferred tax liabilities

-

-

473

446

464

474

446

229

246

380

269

261

272

244

266

292

270

264

227

234

256

277

265

314

319

322

269

308

337

323

Operating lease liabilities

159

164

169

169

134

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other taxes payable

260

257

255

251

261

265

250

266

304

172

89

83

79

73

93

115

123

63

63

59

57

57

57

54

51

49

41

38

33

159

Other noncurrent liabilities

251

229

198

188

181

187

201

204

211

201

213

209

215

248

252

236

246

251

258

288

199

207

176

168

165

168

133

131

121

107

Total liabilities

8,775

8,837

8,594

8,575

8,566

8,592

8,341

6,621

6,715

6,800

7,269

6,056

6,014

6,150

6,117

6,147

6,266

6,822

5,432

5,396

5,125

5,251

5,138

5,239

5,304

5,596

5,393

5,438

5,418

2,221

Commitments and Contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock, $0.01 par value: 1,000,000,000 authorized, none issued

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

Business unit equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

4,183

Common stock, $0.01 par value: 6,000,000,000 authorized; 501,891,243 and 501,891,243 shares issued; 474,865,353 and 475,582,210 shares outstanding at March 31, 2020, and December 31, 2019, respectively

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

5

-

0

Treasury stock, at cost, 27,025,890 and 26,363,033 shares of common stock at March 31, 2020, and December 31, 2019, respectively

2,252

2,042

1,876

1,732

1,593

1,487

1,345

1,215

1,005

852

733

615

510

421

351

294

245

203

150

100

49

0

0

0

-

-

-

-

-

-

Additional paid-in capital

1,017

1,044

1,031

1,019

1,008

1,026

1,010

1,001

990

1,013

1,032

1,024

1,015

1,024

1,014

1,010

1,007

1,012

993

980

969

958

938

923

906

878

876

869

812

0

Retained earnings

4,764

4,427

4,217

3,788

3,495

3,270

3,067

2,722

2,399

2,109

2,140

1,843

1,651

1,477

1,423

1,190

1,016

876

943

795

832

709

661

531

395

276

207

109

13

0

Accumulated other comprehensive loss

-781

-726

-699

-669

-598

-629

-619

-543

-429

-505

-455

-542

-552

-598

-506

-554

-618

-622

-562

-504

-479

-361

-240

-199

-229

-219

-245

-183

-121

-157

Total Zoetis Inc. equity

-

-

-

-

-

-

2,118

1,970

1,960

1,770

1,989

1,715

1,609

1,487

1,585

1,357

1,165

1,068

1,229

1,176

1,278

1,311

1,364

1,260

1,077

940

843

800

709

4,026

Equity attributable to noncontrolling interests

-

-

-

-

-

-

0

12

15

16

30

31

26

12

13

14

22

23

25

26

27

26

25

23

22

22

23

23

15

15

Total equity

2,753

2,708

2,678

2,411

2,317

2,185

2,118

1,982

1,975

1,786

2,019

1,746

1,635

1,499

1,598

1,371

1,187

1,091

1,254

1,202

1,305

1,337

1,389

1,283

1,099

962

866

823

724

4,041

Total liabilities and equity

11,528

11,545

11,272

10,986

10,883

10,777

10,459

8,603

8,690

8,586

9,288

7,802

7,649

7,649

7,715

7,518

7,453

7,913

6,686

6,598

6,430

6,588

6,527

6,522

6,403

6,558

6,259

6,261

6,142

6,262